10 hrs ago
AstraZeneca PLC Dips Into Virtual R&D With Korean Oncology Pact
AstraZeneca and Korea Health Industry Development Institute to establish oncology research program LONDON, UK I March 6, 2014 I AstraZeneca announced today that it has signed a memorandum of understanding with the Korea Health Industry Development Institute to establish an Oncology Research Programme.
Trending on the Topix Network
Sun Mar 09, 2014
Wall St. Cheat Sheet
AstraZeneca Says Nexium Is 'Still Safe' With Ranbaxy Ingredient
AstraZeneca says that Nexium pills made with an ingredient produced in an Indian plant that didn't pass regulatory inspections is still safe to use.
Mon Mar 03, 2014
Customer Interaction Solutions
U.S. FDA Approves Bydureon Pen (exenatide extended-release for...
AstraZeneca today announced that the U.S. Food and Drug Administration has approved the Bydureon Pen 2 mg as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.
Thu Feb 27, 2014
The Motley Fool
AstraZeneca PLC's Renovation Plan Fully Underway
Patent cliffs are still likely to compress revenue for the next year, but AstraZeneca now boasts an appealing pipeline targeting a host of therapeutic classes, including an immuno-oncology pipeline that holds up pretty well to comparisons with Bristol-Myers for the company to show revenue growth absent a large deal.
Tue Feb 25, 2014
Wall Street Journal
AstraZeneca Pursued Forest Labs
British drug maker AstraZeneca PLC recently made an abortive acquisition approach to Forest Laboratories Inc. before the specialty-drug company agreed last week to be bought by Actavis PLC for $25 billion, according to people familiar with the matter.
U.S. FDA approves orphan drug MyaleptTM
MYALEPT, a recombinant analog [laboratory-created form] of human leptin, is the first and only treatment approved by the FDA for these patients.
Mon Feb 24, 2014
AstraZeneca Hits New 1-Year High at $68.38
AstraZeneca 's share price reached a new 52-week high during trading on Monday , ARN reports.
Fri Feb 21, 2014
Chemical Abstracts Service And AstraZeneca PLC Agree To Five-Year SciFinder Contract
The long-term agreement guarantees AstraZeneca researchers access to the most accurate, comprehensive and current research, available only in SciFinder.
Thu Feb 20, 2014
AstraZeneca Patient Assistance Programs Provided More Than Half a...
These programs include AZ&Me and the MedImmune Assistance Program . "At AstraZeneca, we work hard to understand the needs of patients, and we're committed to helping them afford their medications," said Paul Hudson, President, AstraZeneca U.S. and Executive Vice President, North America.
Tue Feb 18, 2014
Pharma Giant AstraZeneca PLC Moves 60 Scientists Into Cancer Research Cambridge Labs
Pharma giant AstraZeneca has entered into a collaboration with the Cancer Research UK Cambridge Institute to temporarily locate up to 60 AZ scientists in the Institute.
Thu Feb 13, 2014
AstraZeneca Receives "Hold" Rating from Berenberg Bank
's stock had its "hold" rating restated by stock analysts at Berenberg Bank in a report issued on Thursday, AR Network reports.
Tue Feb 11, 2014
Wall Street Journal
FDA to Review Clinical Trial Data for AstraZeneca Diabetes Drug
U.S. regulators said Tuesday they are to review clinical trial data for one of AstraZeneca PLC's key diabetes drugs, following concerns expressed in a medical journal last year over increased risk of heart failure.
AstraZeneca PLC Returns Several Compounds To Targacept, Inc.
Biotech company Targacept Inc said British drugmaker AstraZeneca would return rights to several pre-clinical compounds, sending the U.S. company's shares down 10 percent in extended trading.